IL17A and cancer: The aim of this study was to quantitatively summarize the association between intratumoral IL-17A and clinical outcomes in cancer patients, and thereby provided more evidence on the clinical value of IL-17A as a prognostic biomarker and therapeutic target for solid malignances.